Given the frequency of mood disorders in the PWS population, and the fact that more than half of individuals tested have the intermediate or poor phenotype, MTHFR testing or an empirical trial of the supplement L-methyl folate is recommended, especially in patients whose symptoms have been refractory to treatment. The gene discussed is MTHFR; the disease is mood disorder.